DDIT3 and diffuse large B-cell lymphoma: A total of 44 DLBCL patients with high Ki-67 expression in the study group treated with R-EPOCH and 132 DLBCL patients with high Ki-67 expression in the control group treated with R-CHOP were compared via matched-pair analysis.